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HIGHLIGHTS 
• Disinfecting port protectors can be used to reduce CLABSI.
• Implementation of port protectors into nursing culture can be challenging.
• Evidence-based strategies for implementation can be utilized to sustain their use.
Disinfecting port protectors are a supplement to the central line–associated bloodstream 
infection prevention bundle as an optional recommendation from the Centers for Disease 
Control and Prevention. Despite evidence of effectiveness, few centers have successfully 
reported systematic, sustained implementation of these devices. In this article, we discuss 
a successful implementation in a large tertiary care teaching hospital, using an evidence-
based, multidisciplinary approach. 
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Implementation of technology to reduce central line–associated bloodstream infections 
(CLABSIs) can help prevent harm by insulating against human error. However, the use 
of novel devices is not always sustainable owing to a changing workforce, difficulty 
adapting them to unit workflow, and shifting leadership focus.1 
CLABSI harm reduction strategies include scrubbing of the catheter access port with 
disinfectant.2 Up to 54% of CLABSI are preceded by port colonization with the same 
organism.3 Despite this risk, 56% of the nurses surveyed responded that they did not feel 
the need to scrub ports prior to use.4 Additionally, complacency with scrub times may lead 
to inadequate sterilization and infection.5 
Preventative bundle recommendations include the use of alcohol-impregnated 
disinfecting port protectors (AIDPP) to reduce risk from failure of manual 
disinfection.2 Literature has shown their superiority in bioburden reduction when 
compared with port scrubbing with disinfectant6 and efficacy in CLABSI reduction.7 
Our 1,009-bed tertiary care teaching hospital had previously attempted implementation 
of the AIDPP to help reduce ongoing high CLABSI rates. Sub-optimal rollout, perceived 
lack of efficacy by nursing staff, and increased cost to the units led to abandonment of 
the initiative. In response, a multidisciplinary CLABSI harm team decided to reconsider 
implementation strategies. This paper describes how our center successfully 
disseminated and sustained use of the AIDPP for harm reduction evidence-based 
strategies. 
METHODS 
The harm team used the Iowa model of evidence-based practice8 and the 4 tenants of 
the Cullen and Adams evidence-based practice implementation guide9 to embed the 
AIDPP (Curos 3M, St Paul, MN) into the daily nursing workflow (Fig 1). 
 
 
 
 
Fig 1. Timeline for implementation of the AIDPP. Arrows depict the Iowa model 
implementation timeline. Dotted lines demonstrate the integration and overlap of each 
model's systematic approach and successful strategies. AAHC, academic health centers; 
AIDPP, alcohol-impregnated disinfecting port protectors; CLABSI, central line–associated 
bloodstream infection. 
A high CLABSI rate (Problem-Focused Trigger) prompted leadership to endorse the use 
of the AIDPP (Topic Organizational Priority). Implementation was assigned to the harm 
team, given its collaborative position between hospital leadership and the bedside (Form 
a Team). The harm team gathered evidence and critically appraised the use of the AIDPP 
on all intravenous access types (central, peripheral, and dialysis catheters), tubing ports 
and tips, and needleless connectors. 
Prior to launch, an executive summary highlighting the key advantages of these devices 
was distributed to clinicians, organizational leaders, and key stakeholders through 
existing professional councils. Commitment was fostered using a multifaceted approach 
that included vendor onsite training, printed and electronic educational materials, unit 
educator reinforcement, and members of the Infection Prevention Unit Champion 
Committee (IPUCC). 
 
 
The IPUCC was composed of unit-based direct care nurses who have an interest in 
patient safety. Members developed unit-specific educational strategies and met regularly 
to discuss barriers, share success stories, and escalate themes to the harm team who 
could, in turn, escalate to hospital leadership. Figure 2 shows this process created a 
feedback loop, in which priorities were efficiently communicated between leadership and 
bedside nursing. Audit results were presented to the IPUCC and shared with bedside 
nursing to help refine and standardize processes. By rapidly identifying and addressing 
barriers at the bedside, the harm team was able to foster sustainable adherence (Pilot 
the Change in Practice). 
 
Fig 2. Harm team structure and relationship with the Infection Prevention Unit Champion 
Committee. CLABSI, central line–associated bloodstream infection; CMO, chief medical 
officer; CNO, chief nursing officer. 
RESULTS 
A point prevalence survey was performed 4 months postimplementation and showed a 
67% adherence rate. In response, the harm team and the IPUCC developed additional 
unit-specific strategies to increase adherence, including specific education during 
 
 
standardized unit orientation. Nine months postimplementation, the AIDPP were added 
to the CLABSI bundle audit form. Ten months postimplementation, the adherence rate 
increased to 94%. Total CLABSI bundle compliance for 8 months post-implementation 
was 81.9%. 
In the 8 months pre-implementation, the CLABSI rate was 1.36 infections per 1,000 
device days. In the 8 months postimplementation, the rate was sustained at 0.87. There 
was no statistically significant difference in the type of lines infected pre- and 
postimplementation of the AIDPP (Χ2 = 11.259, P value = .13). Similarly, organism 
distribution of CLABSI cases was not significantly different pre- and postimplementation 
(Χ2 = 3.01, P = .22). 
The AIDPP cost an average of $34,000 per month at our hospital. The average CLABSI 
costs approximately $70,696 per event.10 Assuming a consistent patient flow and central 
line utilization rate, our institution had 27 less CLABSI in the 8 months 
postimplementation, which potentially saved an adjusted $1,636,792, accounting for the 
added cost of the protectors. 
DISCUSSION 
The sustainable implementation of the AIDPP reported in this study required a safety 
culture in which leadership placed a high value on the suggestions of bedside providers. 
To our knowledge, this is the first project that described this process for the AIDPP using 
evidence-based strategies. Key evidence and rationale was relayed, from topic experts 
to bedside nurses, using a systematic dissemination and education plan. Early and 
regular connection with nursing, which included a competitive 21-day adherence 
challenge, created a high level of engagement. A structured feedback loop for 
observations and coaching-in-the-moment by the IPUCC helped to create a standard for 
this new practice. Last, inclusion of the AIDPP, as a component of the CLABSI bundle, 
hardwired adherence by audit accountability. 
 
LIMITATIONS 
 
 
Because of the multiple simultaneous quality improvement projects that occurred during 
the implementation period, we cannot state whether the AIDPP were the sole driver of 
CLABSI reduction. Regardless, the evidence to support the use of these devices was 
already robust. There was no control group to investigate if other strategies may have 
been equally viable. Given that this project was implemented within a single center, we 
cannot confirm that strategies used here would apply to other hospital systems. Despite 
this, we believe that the philosophies used for implementation are likely universal and can 
be adopted successfully based on local culture and within pre-existing systems. 
CONCLUSIONS 
Implementation of the AIDPP should include a multidisciplinary approach focused on 
strategic efforts to disseminate education, foster leadership support, and provide 
consistent feedback to units based on identified trends in adherence. 
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